PlainPharmaWatch

CMS Open Payments · Program Year 2024

Acella Pharmaceuticals, LLC

Acella Pharmaceuticals, LLC reported $2,598,222.36 in payments to 1,941 physicians and teaching hospitals across 2,205 transactions.

See the rankings → How this is sourced
$2.6M
Total payments
2,205
Transactions
1,941
Recipients
−$26.1K
General Payments vs PY2023

Acella Pharmaceuticals, LLC reported $2,598,222.36 in payments to 1,941 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #397 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $1.3K per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Acella Pharmaceuticals, LLC pairs top-quartile payment volume with a broadly spread payment pattern across many recipients.

#397
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Acella Pharmaceuticals, LLC's CMS-reported General Payments decreased by $26.1K (−20.1%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ACELLA PHARMACEUTICALS, LLCPY2023: ACELLA PHARMACEUTICALS, LLCPY2024: Acella Pharmaceuticals, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$129.9KPY2024$103.8K
PY2023
$129,901.53
PY2024
$103,839.97

How Acella Pharmaceuticals, LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Acella Pharmaceuticals, LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$2,598,222 Top 21% higher than 79% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Acella Pharmaceuticals, LLC

Averaging $1.2K per transaction and $1.3K per recipient, Acella Pharmaceuticals, LLC's Program Year 2024 total comes to $2,598,222.36 across 2,205 transactions and 1,941 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #397 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

16 transactions worth $65.3K make "Consulting Fee" the top general-payment category in the 4-category breakdown below, 2.5% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Acella Pharmaceuticals, LLC made 4 types of general payments. "Consulting Fee" is the largest category at $65.3K, 2.5% of the company's reported total.

How Acella Pharmaceuticals, LLC divides its payments

Top payment categories by total reported dollar volume

1. Consulting Fee$65.3K2. Food and Beverage$34.8K3. Travel and Lodging$2.8K4. Compensation for Services…$840.55
Payment Type Amount Transactions
Consulting Fee $65.3K 16
Food and Beverage $34.8K 1,918
Travel and Lodging $2.8K 6
Compensation for Services Other Than Consulting $840.55 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $55,859.57 (53.8%) of $103,839.97 in this company's General Payments records across 1,609 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Acella Pharmaceuticals, LLC

The five named recipients with the highest reported General Payments from this company

Elizabeth Mcaninch$15.0KThanh Hoang$11.7KDavid Robertson$11.2KMandy Beth Cotten$9.0KAngela Mazza$8.9K
  1. 1

    Elizabeth Mcaninch

    $15,038.84 across 4 reported transactions

  2. 2

    Thanh Hoang

    $11,652.50 across 3 reported transactions

  3. 3

    David Robertson

    $11,230.69 across 2 reported transactions

  4. 4

    Mandy Beth Cotten

    $8,995.59 across 4 reported transactions

  5. 5

    Angela Mazza

    $8,941.95 across 4 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.2K. Average per recipient: $1.3K.

Total Amount

$2,598,222.36

Avg per Transaction

$1.2K

Avg per Recipient

$1.3K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Acella Pharmaceuticals, LLC Share

0.0%

#397 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Acella Pharmaceuticals, LLC

Purdue Pharma L.P.

$2.6M 309 recipients

Cipla USA Inc.

$2.6M 80 recipients

Tosoh Bioscience, Inc.

$2.6M 9 recipients

Cerus Corporation

$2.6M 372 recipients

Ardelyx, Inc.

$2.6M 42,247 recipients

Global Blood Therapeutics, Inc.

$2.7M 0 recipients

Frequently Asked Questions

How much did Acella Pharmaceuticals, LLC pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Acella Pharmaceuticals, LLC, totaling $2,598,222.36 across 2,205 transactions to physicians and hospitals.
How many physicians received payments from Acella Pharmaceuticals, LLC? ▾
Averaging $1.3K per recipient, Acella Pharmaceuticals, LLC's 2024 payments reached 1,941 physicians and teaching hospitals.
What types of payments did Acella Pharmaceuticals, LLC make? ▾
4 categories of general payment make up Acella Pharmaceuticals, LLC's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $65.3K, representing 2.5% of the company's reported total.
How does Acella Pharmaceuticals, LLC rank among pharmaceutical companies? ▾
By total payment amount, Acella Pharmaceuticals, LLC sits at #397 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Acella Pharmaceuticals, LLC? ▾
Acella Pharmaceuticals, LLC's 2,205 transactions to 1,941 recipients in 2024 averaged $1.2K per transaction.
Where does the payment data for Acella Pharmaceuticals, LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Acella Pharmaceuticals, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.